# NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

> **NCT04167085** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 26 (actual)

## Conditions studied

- Epistaxis

## Interventions

- **DRUG:** Doxycycline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04167085
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-18
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04167085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04167085, "NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04167085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*